Recruitment Paused at NEIGRIHMS Over Controversy on Gender Representation

Published On 2025-05-06 07:46 GMT   |   Update On 2025-05-06 07:46 GMT
Advertisement

Shillong: The North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS) on Monday decided to halt the upcoming recruitment processes after social organisations here protested demanding the implementation of an 80:20 female-to-male ratio of employees.

The decision in this regard was taken after government spokesperson Paul Lyngdoh chaired a meeting with officials of the NEIGRIHMS and a delegation of the influential Khasi Students Union (KSU).

Advertisement

The KSU had been protesting inside the NEIGRIHMS campus demanding, among others, the implementation of the ratio, reviewing the roster registry and setting up examination centres across Meghalaya.

Also Read:NEIGRIHMS seeks CAPF deployment after mob breach

Lyngdoh said, “In view of these developments, it was decided that until all matters are sorted out, the NEIGRIHMS will halt the entire recruitment process.” The issues will be addressed in a week or so, he hoped.

Advertisement

Lyngdoh said that a government delegation will seek immediate appointment with the union minister of Health & Family Welfare for taking up the issues, which are beyond the administrative control of NEIGRIHMS.

“As you are aware, there is also a governing council of the NEIGRIHMS chaired by the union minister of health and we have decided that parallelly, these issues will also be taken up at the level of the governing council. Resolutions adopted by the governing council will then be forwarded to the union ministry,” he said.

Established in 1987, NEIGRIHMS is the first postgraduate medical institution in the North Eastern region.

Also Read:NEIGRIHMS doctors win Award for Cataract Research Study

Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News